ARCHIVES

Aromasin Approved By FDA For ER+ Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 10 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

Controversy Raging On Whether To Release Data On 5-FU/Levamisole, Stop Untreated Control Arm

June 9, 1989

NCI, MABCO Publish Clinical Trials Web Site

September 6, 1996

NCI To Use Technology Transfer Agreement To Privatize Journal In A Five-Year Deal

December 1, 1995

Proposed Deal Could Resolve Key Disputes At NSABP, Pitt

January 13, 1995

Duke wins Avon-NCI funding.

October 31, 2003

Breast Cancers Detected By Mammograms Have Better Prognosis, Trials Analysis Finds

September 30, 2005